Cancer among Swedish military and civilian personnel in UN missions in the Balkans, 1989–99
| Cancer site | ICD-7* code | Military personnel | Civil personnel | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Men | Women | Men | |||||||||||
| Obs† | Exp‡ | SIR§ | 95% CI¶ | Obs | Exp | SIR | 95% CI | Obs | Exp | SIR | 95% CI | ||
| *International classification of diseases, 7th revision. | |||||||||||||
| †Observed number of cases. | |||||||||||||
| ‡Expected number of cases. | |||||||||||||
| §Standardised incidence ratio, not calculated if there were less than two cases. | |||||||||||||
| ¶95% confidence interval. | |||||||||||||
| All sites | 140–209 | 26 | 21.8 | 1.2 | 0.8 to 1.8 | 4 | 2.6 | 1.5 | 0.4 to 3.9 | 4 | 3.8 | 1.1 | 0.3 to 2.7 |
| Oral cavity | 143–144 | 1 | 0.1 | 0.0 | 0.0 | ||||||||
| Rectum | 154 | 2 | 0.5 | 3.9 | 0.5 to 14 | 0.0 | 0.2 | ||||||
| Liver, not specified as primary | 155.1–9 | 0.1 | 0.0 | 1 | 0.0 | ||||||||
| Bronchus and lung | 162.1 | 1 | 0.8 | 1 | 0.1 | 1 | 0.3 | ||||||
| Cervix uteri | 171 | − | 1 | 0.2 | – | ||||||||
| Testis | 178 | 8 | 4.3 | 1.9 | 0.8 to 3.7 | − | 0.2 | ||||||
| Urinary bladder | 181.0 | 2 | 0.7 | 2.9 | 0.4 to 11 | 0.0 | 0.2 | ||||||
| Malignant melanoma | 190 | 2 | 2.2 | 0.9 | 0.1 to 3.3 | 1 | 0.3 | 1 | 0.3 | ||||
| Brain and nervous system | 193 | 3 | 2.6 | 1.2 | 0.2 to 3.4 | 1 | 0.2 | 1 | 0.3 | ||||
| Endocrine glands | 195 | 1 | 0.7 | 0.1 | 0.1 | ||||||||
| Unknown site | 199 | 1 | 0.6 | 0.0 | 0.1 | ||||||||
| Haematolymphatic organs | 200–209 | 5 | 3.5 | 1.4 | 0.5 to 3.3 | 0.2 | 0.5 | ||||||
| Non-Hodgkin’s lymphoma | 200 | 1 | 1.2 | 0.1 | 0.2 | ||||||||
| Hodgkin’s disease | 201 | 2 | 1.1 | 1.9 | 0.2 to 6.7 | 0.0 | 0.0 | ||||||
| Myelomatosis | 203 | 1 | 0.2 | 0.0 | 0.1 | ||||||||
| Chronic myeloid leukaemia | 205.1 | 1 | 0.3 | 0.0 | 0.0 | ||||||||